BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/15/2023 3:41:16 PM | Browse: 341 | Download: 904
 |
Received |
|
2022-10-27 14:31 |
|
Peer-Review Started |
|
2022-10-27 14:33 |
|
First Decision by Editorial Office Director |
|
2022-12-26 08:30 |
|
Return for Revision |
|
2022-12-26 08:30 |
|
Revised |
|
2022-12-27 12:28 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-02-10 03:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-02-10 18:18 |
|
Articles in Press |
|
2023-02-10 18:18 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-09 10:36 |
|
Publish the Manuscript Online |
|
2023-03-15 15:41 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biology |
| Manuscript Type |
Minireviews |
| Article Title |
Carbamylated lipoproteins in diabetes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Damien Denimal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Damien Denimal, PharmD, PhD, Assistant Professor, Department of Biochemistry, University Hospital of Dijon, 2 rue Ducoudray, BP 37013, Dijon 21079, France. damien.denimal@u-bourgogne.fr |
| Key Words |
Carbamylation; Lipoprotein; Diabetes; Low-density lipoprotein; High-density lipoprotein; Myeloperoxidase |
| Core Tip |
There is growing evidence that carbamylation of lipoproteins occurring in diabetes contributes to the pathophysiology of atherosclerosis, and therefore plays a role in the cardiovascular risk. Numerous studies have demonstrated that carbamylated low-density lipoproteins (LDL) is more atherogenic than native LDL, citing, for instance, its role in foam cell formation or ability to damage endothelial function. In addition, carbamylated high-density lipoproteins exhibits reduced antiatherogenic properties, especially in terms of the capacity to induce cholesterol efflux from macrophages and to protect endothelium. |
| Publish Date |
2023-03-15 15:41 |
| Citation |
Denimal D. Carbamylated lipoproteins in diabetes. World J Diabetes 2024; In press |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i3/159.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i3.159 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
